ECSP034840A - N-FORMIL-HYDROXYLAMINE COMPOUNDS AS PDF INHIBITORS - Google Patents
N-FORMIL-HYDROXYLAMINE COMPOUNDS AS PDF INHIBITORSInfo
- Publication number
- ECSP034840A ECSP034840A ECSP034840A ECSP034840A EC SP034840 A ECSP034840 A EC SP034840A EC SP034840 A ECSP034840 A EC SP034840A EC SP034840 A ECSP034840 A EC SP034840A
- Authority
- EC
- Ecuador
- Prior art keywords
- formil
- hydroxylamine compounds
- pdf inhibitors
- 7alkanes
- treatment
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Los N-[1-oxo-2-alquil-3-(N-hidroxiformamido)-propil]-(carbonilamino-aril ó -heteroaril)-azaciclo4-7alcanos o tiazaciclo4-7alcanos o imidazaciclo4-7alcanos, tienen propiedades interesantes, por ejemplo en el tratamiento o la prevención de desórdenes susceptibles al tratamiento mediante inhibidores de peptidil-desformilasa, tal como el tratamiento de infecciones bacterianas.The N- [1-oxo-2-alkyl-3- (N-hydroxyformamide) -propyl] - (carbonylamino-aryl or -heteroaryl) -azacyclo4-7alkanes or thiazacyclo4-7alkanes or imidazacycle4-7alkanes, for example, in the treatment or prevention of disorders susceptible to treatment by peptidyl deformylase inhibitors, such as the treatment of bacterial infections.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29841901P | 2001-06-15 | 2001-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034840A true ECSP034840A (en) | 2004-01-28 |
Family
ID=40418798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034840 ECSP034840A (en) | 2001-06-15 | 2003-11-11 | N-FORMIL-HYDROXYLAMINE COMPOUNDS AS PDF INHIBITORS |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101654451A (en) |
| EC (1) | ECSP034840A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103159660B (en) * | 2011-12-08 | 2016-07-06 | 天津市国际生物医药联合研究院 | (2R)-1-(2-methyl-3-(methoxyl group (methyl) amino)-propiono) pyrrolidine-2-carboxylic acid and application thereof |
-
2002
- 2002-06-14 CN CN200910165395A patent/CN101654451A/en active Pending
-
2003
- 2003-11-11 EC ECSP034840 patent/ECSP034840A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101654451A (en) | 2010-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0102315D0 (en) | Compounds | |
| SE0301700D0 (en) | Novel compounds | |
| NO20065847L (en) | Diphenylimidazopyrimidines and imidazolamines as inhibitors of B-secretase | |
| CY1107688T1 (en) | BICYCLE PYRROLIDINE COMPOUNDS | |
| NO20052888L (en) | Diamin triazoles useful as inhibitors of protein kinases | |
| CR9580A (en) | AKT ACTIVITY INHIBITORS | |
| DK1556021T3 (en) | Pharmaceutical compositions comprising flavonoids and menthol as well as methods of treatment using said compositions | |
| ATE433973T1 (en) | AZOLYLAMINOAZINES AS INHIBITORS OF PROTEIN KINASES | |
| ATE368031T1 (en) | NEW GAMMA SECRETASE INHIBITORS | |
| ATE408601T1 (en) | FREDERICAMYCIN DERIVATIVES | |
| CY1105085T1 (en) | N-FORMYL HYDROXYLAMINE COMPOUNDS AS PDF INHIBITORS | |
| NO20054371L (en) | Somatostatin-dopamine chimeric analogs | |
| ATE466856T1 (en) | COMPOUNDS AND METHODS FOR TREATING OR PREVENTING FLAVIVIRUS INFECTIONS | |
| DK1641803T3 (en) | Thienopyrimidine derivatives as potassium channel inhibitors | |
| DK1448562T3 (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
| ATE549024T1 (en) | QUINAZOLINE POTASSIUM CHANNEL INHIBITORS | |
| BRPI0509667A (en) | Substituted azaquinazolines with antiviral efficacy | |
| DE60317935D1 (en) | ALPHA AMINOAMIDE DERIVATIVES AS AGENTS AGAINST MIGRAINE | |
| ATE476419T1 (en) | ISOQUINOLINONE POTASSIUM CHANNEL INHIBITORS | |
| SE0300457D0 (en) | Novel compounds | |
| ATE346040T1 (en) | ARYL SULFONAMIDE AS SEROTONIN ANTAGONISTS FOR THE TREATMENT OF OBESITY | |
| HUP0401633A2 (en) | Use of irbesartan for the preparation of pharmaceutical compositions that are used to prevent or treat pulmonary hypertension | |
| ECSP034840A (en) | N-FORMIL-HYDROXYLAMINE COMPOUNDS AS PDF INHIBITORS | |
| EP1682518A4 (en) | Dicationic triaryl analogs as anti-protozoan agents | |
| ATE536874T1 (en) | TRIPLE MONOAMINE REUPPOST INHIBITORS FOR THE TREATMENT OF CHRONIC PAIN |